Explore more Norwegian companies →
COMPANY CARD COMPANY
APPSENS AS
Manufacture of pharmaceutical preparations
-96,1 % EBIT margin
FINANCIALS
Financial statements and key figures
Company financial statements
Amount in NOK
| Financial statement item | 2025 | 2024 | 2023 |
|---|---|---|---|
| Currency | NOK | NOK | NOK |
| Operating revenue | 10 802 461 | 6 975 448 | 5 106 547 |
| Operating profit | -10 377 480 | -8 842 143 | -12 749 396 |
| Net income | -10 321 527 | -8 631 632 | -12 901 769 |
| Equity | 7 494 422 | 17 815 949 | 14 271 774 |
| Total assets | 15 181 051 | 23 649 670 | 19 691 896 |
| EBIT margin | -96,1 % | -126,8 % | -249,7 % |
Indicators: equity / assets and EBIT / operating revenue. Midline is 0%, scale −100% to +100%. Not a credit assessment.
Show trend in NOK
Click the year markers for exact amounts. Missing years create gaps. The financial statement table above shows all amounts.
Click the year markers for exact amounts. Missing years create gaps. The financial statement table above shows all amounts.
Sources and conversion basis
Companies and corporate groups are kept separate. The same historical annual exchange rate is used for income statement and balance sheet figures. Missing values are shown as “—”. Actual zero values are retained.
- 2025 · NOK · original-NOK · source version ae3871ef417b
- 2024 · NOK · original-NOK · source version 520a236d2d77
- 2023 · NOK · original-NOK · source version 2c169036dc0b
Expand for more financial statement items. We show items with information in at least one year. “—” means a value is missing for that year.
Income statement3 entries with information
| Financial statement item | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating revenue | |||
| Total operating revenue | 10 802 461 | 6 975 448 | 5 106 547 |
| Operating profit | |||
| Operating income (EBIT) | -10 377 480 | -8 842 143 | -12 749 396 |
| Results and tax | |||
| Net income | -10 321 527 | -8 631 632 | -12 901 769 |
Balance sheet2 entries with information
| Financial statement item | 2025 | 2024 | 2023 |
|---|---|---|---|
| Current assets | |||
| Total assets | 15 181 051 | 23 649 670 | 19 691 896 |
| Equity | |||
| Total equity | 7 494 422 | 17 815 949 | 14 271 774 |
Executive salaryUnavailable
No information in the available financial statement data.
REGISTRY INFORMATION
Company at a glance
- Industry
- 21.200 · Manufacture of pharmaceutical preparations Industry classification: Statistics Norway · CC BY 4.0
- Registered address
- Senterveien 30, 4790 LILLESAND
- Founded
- 03.03.2017
- Entity type
- Main entity
ADDRESS AND PROPERTY
Property information
Senterveien 30, 4790 LILLESAND
Companies at the same address
Available company cards
About the address match
Same registered street address, postal code, and municipality. This does not document ownership, tenancy, or who uses the building. The address match does not identify a specific unit or dwelling. Open information does not show titleholders, sale date, plot area, or a complete building overview.
REGISTERED ROLES
The people and companies behind it.
Source: Brønnøysund Register Centre. A registered role is not documentation of direct contact information.
YEAR-DATED OWNERSHIP
Reported shareholders.
As of 31 December 2025 · 10 of 46 available ownership entries
- UTHALDEN ASOrdinary shares20,11 %
- AGDER SEED ASOrdinary shares11,87 %
- BJØRN BREIEN ASOrdinary shares11,07 %
- FENSLI CONSULTING ASOrdinary shares11,07 %
- LUCELLUM ASOrdinary shares6,55 %
- Other / undisplayed records39,34 %
Fixed scale 0–100%. Shares are not normalized. Any unfilled portion is outside the displayed total.
Multiple company owners (27)
Source: Skatteetaten. Ownership share is a share of the number of shares, not necessarily voting rights or control. Person names refer to separate source records. Similar names are not automatically the same person.
Previously reported ownership entries (92)
- 2024 · UTHALDEN AS · 20,11 %
- 2024 · AGDER SEED AS · 11,87 %
- 2024 · BJØRN BREIEN AS · 11,07 %
- 2024 · FENSLI CONSULTING AS · 11,07 %
- 2024 · LUCELLUM AS · 6,55 %
- 2024 · CORSULT AS · 5,82 %
- 2024 · VERD INVESTERING AS · 4,95 %
- 2024 · ERBE INVEST AS · 4,10 %
- 2024 · GREMSDALEN INVEST AS · 3,54 %
- 2024 · GUMPENS INVEST AS · 3,05 %
- 2024 · MA-INVEST AS · 1,70 %
- 2024 · FENSLI INVEST AS · 1,48 %
- 2024 · CONTINA AS · 1,38 %
- 2024 · SOLLYS INVEST AS · 1,19 %
- 2024 · AXCE HOLDING AS · 0,96 %
- 2024 · LEXA INVEST AS · 0,96 %
- 2024 · MORTEN NESET · 0,92 %
- 2024 · RESULTATFORUM AS · 0,71 %
- 2024 · PAGIN HOLDING AS · 0,65 %
- 2024 · JENS PETTER RØNNING · 0,65 %
- 2024 · SIFRE AS · 0,64 %
- 2024 · SEVEN PEAKS NORWAY AS · 0,62 %
- 2024 · NORDEN CORPORATE FINANCE AS · 0,58 %
- 2024 · DR.NO INVEST AS · 0,56 %
- 2024 · NIVEST AS · 0,53 %
- 2024 · CETIUM AS · 0,46 %
- 2024 · HIGEN HOLDING AS · 0,45 %
- 2024 · ASPHEIMEN AS · 0,38 %
- 2024 · GS CONSULTING AS · 0,38 %
- 2024 · BOBE INVEST AS · 0,34 %
- 2024 · KJETIL TODNEM · 0,34 %
- 2024 · CONCORDIA VIKING AS · 0,28 %
- 2024 · TOR REIER LILLEHOLT · 0,27 %
- 2024 · TRIPPEL S AS · 0,20 %
- 2024 · EK KONSULENTTJENESTER AS · 0,19 %
- 2024 · STAFF INVEST AS · 0,18 %
- 2024 · SIRI LINDLAND · 0,13 %
- 2024 · CILARIS AS · 0,12 %
- 2024 · OLE JACOB ØSTBERG · 0,11 %
- 2024 · FRIMAN AS · 0,11 %
- 2024 · SMESTAD MEDISINSKE SENTER AS · 0,11 %
- 2024 · SMESTADKLINIKKEN AS · 0,11 %
- 2024 · KJELL JARL HJELLE · 0,07 %
- 2024 · PER LARSEN · 0,06 %
- 2024 · MARIE AMALIE GUTTORMSEN · 0,06 %
- 2024 · JGB CORPORATE AS · 0,02 %
- 2023 · BJØRN BREIEN AS · 13,96 %
- 2023 · FENSLI CONSULTING AS · 13,95 %
- 2023 · UTHALDEN AS · 12,58 %
- 2023 · CORSULT AS · 7,23 %
- 2023 · LUCELLUM AS · 6,68 %
- 2023 · VERD INVESTERING AS · 6,24 %
- 2023 · OLE ANDREAS LILJEDAHL SANDBERG · 5,28 %
- 2023 · ERBE INVEST AS · 5,17 %
- 2023 · GREMSDALEN INVEST AS · 4,32 %
- 2023 · AGDER SEED AS · 4,27 %
- 2023 · GUMPENS INVEST AS · 3,84 %
- 2023 · AXCE HOLDING AS · 1,21 %
- 2023 · LEXA INVEST AS · 1,21 %
- 2023 · MORTEN NESET · 1,16 %
- 2023 · FENSLI INVEST AS · 1,05 %
- 2023 · RESULTATFORUM AS · 0,89 %
- 2023 · JENS PETTER RØNNING · 0,81 %
- 2023 · SIFRE AS · 0,80 %
- 2023 · SEVEN PEAKS NORWAY AS · 0,78 %
- 2023 · NIVEST AS · 0,67 %
- 2023 · PAGIN HOLDING AS · 0,67 %
- 2023 · CETIUM AS · 0,58 %
- 2023 · DR.NO INVEST AS · 0,58 %
- 2023 · NORDEN CORPORATE FINANCE AS · 0,58 %
- 2023 · HIGEN HOLDING AS · 0,57 %
- 2023 · ASPHEIMEN AS · 0,48 %
- 2023 · GS CONSULTING AS · 0,48 %
- 2023 · CONTINA AS · 0,46 %
- 2023 · BOBE INVEST AS · 0,43 %
- 2023 · SOLLYS INVEST AS · 0,43 %
- 2023 · KJETIL TODNEM · 0,35 %
- 2023 · TOR REIER LILLEHOLT · 0,34 %
- 2023 · EK KONSULENTTJENESTER AS · 0,24 %
- 2023 · CONCORDIA VIKING AS · 0,23 %
- 2023 · STAFF INVEST AS · 0,23 %
- 2023 · TRIPPEL S AS · 0,20 %
- 2023 · CILARIS AS · 0,16 %
- 2023 · FRIMAN AS · 0,14 %
- 2023 · SMESTAD MEDISINSKE SENTER AS · 0,13 %
- 2023 · SMESTADKLINIKKEN AS · 0,13 %
- 2023 · OLE JACOB ØSTBERG · 0,12 %
- 2023 · SIRI LINDLAND · 0,11 %
- 2023 · KJELL JARL HJELLE · 0,09 %
- 2023 · MARIE AMALIE GUTTORMSEN · 0,07 %
- 2023 · PER LARSEN · 0,06 %
- 2023 · JGB CORPORATE AS · 0,02 %
YEAR-DATED OWNERSHIP
Company share entries
The company’s own investments in other businesses. Shareholders who own the company are shown under Ownership.
Source and scope
Skatteetaten / Aksjonærregisteret. Every level uses the same source year and source set. Further links follow Norwegian business registration numbers; foreign identifiers are not linked automatically. Calculated share is the product of reported share count / total shares at each level, not voting rights, control, or today’s shareholder register. Partial source coverage is stated at the relevant level; unresolved calculation basis is shown without a percentage.
Up to 500 source records examined; the view may be limited. Missing matches do not prove that ownership is absent.
YEAR-DATED OWNERSHIP
Indirect ownership
Explore documented ownership paths through companies. Each path and share class is shown separately; shares are not added together.
Source and scope
Skatteetaten / Aksjonærregisteret. Every level uses the same source year and source set. Further links follow Norwegian business registration numbers; foreign identifiers are not linked automatically. Calculated share is the product of reported share count / total shares at each level, not voting rights, control, or today’s shareholder register. Partial source coverage is stated at the relevant level; unresolved calculation basis is shown without a percentage.
Up to four ownership levels, 32 company lookups, and 250 chains are examined within a short time budget. This is a limited selection, not a ranking of the largest 250. Cycles are stopped. Missing matches do not prove that ownership is absent.
CONNECTIONS
Explore the ownership structure.
Directly reported ownership entries are shown first. Open the map to explore further.
Direct ownership entries without an interactive map
As of 31 December 2025 · 10 of 46 available ownership entries
Multiple company owners (27)
Source: Skatteetaten / Aksjonærregisteret. Year-dated share ownership is not necessarily today’s voting rights or corporate control.
Open interactive map for direct ownership entries
CONNECTIONS
Explore the ownership structure.
See owners and open further company levels, using the same year throughout the tree.
Click a company to open owners. Select i for details.